Skip to main content
Fig. 4 | Biomarker Research

Fig. 4

From: Small molecule tyrosine kinase inhibitors modulated blood immune cell counts in patients with oncogene-driven NSCLC

Fig. 4

Kaplan-Meier PFS and OS estimates by lymphocyte counts according to NSCLC cohorts. Median PFS (A) and OS (B) of NSCLC patients are illustrated according to cohort A and B, respectively. Groups were compared using the log-rank test. Receiver operating characteristic (ROC) curves analysis for ALCs (C) and CD4 plus CD8 (D) in enrolled NSCLC patients (N = 62) are shown. Tick marks indicate censored data. Groups were compared using the Z test. P < 0.05 for statistical significance

Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us